Europe Finalises the Approval of the First Drug that Fights Narcolepsy, the Disease that Jordi Évole Has: 'Patients Change Their Lives'
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
The head of the Neurophysiology Service and the Dream Unit of the Hospital de la Ribera (Valencia) and member of the Spanish Dream Society (SES), Javier Puertas, hopes that in a period of six months to one year the European Medicines Agency (EMA) will approve 'Orzeyful' (oveporextona), the first drug to combat the cause of narcolepsy.
lacronicabadajoz.com
Between 15,000 and 25,000 people in Spain have narcolepsy, a chronic neurological sleep disorder suffered by journalist Jordi Évole who, on various occasions, has claimed a greater understanding of the disease. The positive thing is that sleep medicine experts hope that, very soon - between six months and one year - the drug oveporextone will be approved in Europe, the first to combat the cause of a disease that in many people is undiagnosed. "P…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
